NCT04617782View on ClinicalTrials.gov

Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

April 5, 2021

Study Completion Date

April 5, 2021

Conditions

Healthy Subjects

Interventions

COMBINATION_PRODUCT

Donepezil TDS

Transdermal Delivery System

DRUG

Aricept

Oral

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors

lead

Corium, Inc.

INDUSTRY

NCT04617782 - Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers | Biotech Hunter | Biotech Hunter